<SEC-DOCUMENT>0001213900-16-019477.txt : 20170418
<SEC-HEADER>0001213900-16-019477.hdr.sgml : 20170418
<ACCEPTANCE-DATETIME>20161216145219
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001213900-16-019477
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20161216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Therapix Biosciences Ltd.
		CENTRAL INDEX KEY:			0001611746
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1213

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		SCIENCE PARK, 18 EINSTIEN ST.
		STREET 2:		P.O BOX 4122
		CITY:			NESS-ZIONA
		STATE:			L3
		ZIP:			7414002
		BUSINESS PHONE:		972-8-9396577

	MAIL ADDRESS:	
		STREET 1:		SCIENCE PARK, 18 EINSTIEN ST.
		STREET 2:		P.O BOX 4122
		CITY:			NESS-ZIONA
		STATE:			L3
		ZIP:			7414002
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: right; margin-right: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
16, 2016</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>VIA
EDGAR</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Securities and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Division
of Corporation Finance</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington,
DC 20549</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THERAPIX
    BIOSCIENCES LTD.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 96px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration Statement
    on Form F-1 (Registration No. 333-214458) </B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 96px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Concurrence in
    Acceleration Request</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.C.
Wainwright &amp; Co., LLC (&ldquo;<U>Wainwright</U>&rdquo;), as representative of the underwriters for the referenced offering,
hereby concurs in the request by Therapix Biosciences Ltd. that the effective date of the above-referenced registration statement
be accelerated to 5:00 p.m. (Eastern Time), or as soon as practicable thereafter, on December 20, 2016, pursuant to Rule 461 under
the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act in connection with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Very truly yours,</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">H.C. WAINWRIGHT &amp; CO., LLC</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0 0 1.5pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0 0 1.5pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Mark W. Viklund</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Mark W. Viklund<BR>
 Title: Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  1 1H# 2(  A$! Q$!_\0
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(HHB9U>A__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
